Merit Medical Shares Rise Following Preliminary Sales Forecast, CEO Pick

Dow Jones

2025/07/08

By Katherine Hamilton

Merit Medical Systems shares rose after the company said it expects sales to come in ahead of Wall Street expectations and it chose a new chief executive to replace its founder and long-time head.

The stock advanced 5% to $95.52 in after-hours trading on Monday.

The South Jordan, Utah, company gave a preliminary revenue estimate of $380 million to $384 million for the second quarter. That would be ahead of the $372.5 million analysts are forecasting, according to FactSet.

That comes after Merit in April cut its full-year adjusted earnings outlook due to the projected affect of tariffs.

Merit also named Martha Aronson as chief executive and president. She will succeed Fred Lampropoulos, who founded the company in 1987 and has been chief executive since then.

The transition is scheduled for Oct. 3. Lampropoulos will serve as chairman after that.

Write to Katherine Hamilton at katherine.hamilton@wsj.com

(END) Dow Jones Newswires

July 07, 2025 17:52 ET (21:52 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

应版权方要求，你需要登录查看该内容

登录 / 注册

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2549630563"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2549630563\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2549630563?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-07-08 05:52","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2549630563","market":"fut","top_or_hot":-1,"title":"Merit Medical Shares Rise Following Preliminary Sales Forecast, CEO Pick","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Katherine <a href=\"https://laohu8.com/S/HBK\">Hamilton</a> \n</p>\n<p>\n  <a href=\"https://laohu8.com/S/MMSI\">Merit Medical Systems</a> shares rose after the company said it expects sales to come in ahead of Wall Street expectations and it chose a new chief executive to replace its founder and long-time head. \n</p>\n<p>\n  The stock advanced 5% to $95.52 in after-hours trading on Monday. \n</p>\n<p>\n  The South Jordan, Utah, company gave a preliminary revenue estimate of $380 million to $384 million for the second quarter. That would be ahead of the $372.5 million analysts are forecasting, according to FactSet. \n</p>\n<p>\n  That comes after Merit in April cut its full-year adjusted earnings outlook due to the projected affect of tariffs. \n</p>\n<p>\n  Merit also named Martha Aronson as chief executive and president. She will succeed Fred Lampropoulos, who founded the company in 1987 and has been chief executive since then. \n</p>\n<p>\n  The transition is scheduled for Oct. 3. Lampropoulos will serve as chairman after that. \n</p>\n<p>\n  Write to Katherine Hamilton at katherine.hamilton@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  July 07, 2025 17:52 ET (21:52 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Merit Medical Shares Rise Following Preliminary Sales Forecast, CEO Pick</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMerit Medical Shares Rise Following Preliminary Sales Forecast, CEO Pick\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-07-08 05:52</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Katherine <a href=\"https://laohu8.com/S/HBK\">Hamilton</a> \n</p>\n<p>\n  <a href=\"https://laohu8.com/S/MMSI\">Merit Medical Systems</a> shares rose after the company said it expects sales to come in ahead of Wall Street expectations and it chose a new chief executive to replace its founder and long-time head. \n</p>\n<p>\n  The stock advanced 5% to $95.52 in after-hours trading on Monday. \n</p>\n<p>\n  The South Jordan, Utah, company gave a preliminary revenue estimate of $380 million to $384 million for the second quarter. That would be ahead of the $372.5 million analysts are forecasting, according to FactSet. \n</p>\n<p>\n  That comes after Merit in April cut its full-year adjusted earnings outlook due to the projected affect of tariffs. \n</p>\n<p>\n  Merit also named Martha Aronson as chief executive and president. She will succeed Fred Lampropoulos, who founded the company in 1987 and has been chief executive since then. \n</p>\n<p>\n  The transition is scheduled for Oct. 3. Lampropoulos will serve as chairman after that. \n</p>\n<p>\n  Write to Katherine Hamilton at katherine.hamilton@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  July 07, 2025 17:52 ET (21:52 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MMSI","symbol_name":"Merit Medical Systems","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2549630563","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2549630563","pubTimestamp":1751925120,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Merit Medical Systems shares rose after the company said it expects sales to come in ahead of Wall Street expectations and it chose a new chief executive to replace its founder and long-time head.The stock advanced 5% to $95.52 in after-hours trading on Monday.The South Jordan, Utah, company gave a preliminary revenue estimate of $380 million to $384 million for the second quarter. That would be ahead of the $372.5 million analysts are forecasting, according to FactSet.That comes after Merit in April cut its full-year adjusted earnings outlook due to the projected affect of tariffs.Merit also named Martha Aronson as chief executive and president. She will succeed Fred Lampropoulos, who founded the company in 1987 and has been chief executive since then.The transition is scheduled for Oct. 3. Lampropoulos will serve as chairman after that.","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"MMSI":"Merit Medical Systems"},"translate_title":"首席执行官选择初步销售预测后，Merit Medical股价上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MMSI":1},"content_text":"By Katherine Hamilton\n\n\nMerit Medical Systems shares rose after the company said it expects sales to come in ahead of Wall Street expectations and it chose a new chief executive to replace its founder and long-time head. \n\n\n  The stock advanced 5% to $95.52 in after-hours trading on Monday. \n\n\n  The South Jordan, Utah, company gave a preliminary revenue estimate of $380 million to $384 million for the second quarter. That would be ahead of the $372.5 million analysts are forecasting, according to FactSet. \n\n\n  That comes after Merit in April cut its full-year adjusted earnings outlook due to the projected affect of tariffs. \n\n\n  Merit also named Martha Aronson as chief executive and president. She will succeed Fred Lampropoulos, who founded the company in 1987 and has been chief executive since then. \n\n\n  The transition is scheduled for Oct. 3. Lampropoulos will serve as chairman after that. \n\n\n  Write to Katherine Hamilton at katherine.hamilton@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  July 07, 2025 17:52 ET (21:52 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"executive,dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}